Boston Scientific (BSX) gross profit was $13.9B in FY2025 (+21% YoY). The tables below show the complete quarterly and annual gross profit history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Gross Profit
Fiscal Year
Gross Profit
YoY
2025
$13.9B
+21%
2024
$11.5B
+16%
2023
$9.9B
+13%
2022
$8.7B
+7%
2021
$8.2B
+27%
2020
$6.4B
-15%
2019
$7.6B
+9%
2018
$7.0B
+9%
2017
$6.5B
+8%
2016
$6.0B
+12%
2015
$5.3B
+3%
2014
$5.2B
+4%
2013
$5.0B
+1%
2012
$4.9B
-1%
2011
$5.0B
-5%
2010
$5.2B
-7%
2009
$5.6B
+1%
2008
$5.6B
-7%
2007
$6.0B
Recent Quarterly Gross Profit
Quarter
Gross Profit
Q2 2026
$3.8B
Q1 2026
$3.6B
Q4 2025
$3.7B
Q3 2025
$3.5B
Q2 2025
$3.4B
Q1 2025
$3.2B
Q4 2024
$3.1B
Q3 2024
$2.9B
Q2 2024
$2.9B
Q1 2024
$2.6B
Q4 2023
$2.6B
Q3 2023
$2.4B
Source: BSX on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.